Prevalence of atrial fibrillation in the general population and in high-risk groups: the ECHOES study

被引:143
作者
Davis, Russell C. [1 ]
Hobbs, F. D. Richard [2 ]
Kenkre, Joyce E. [3 ]
Roalfe, Andrea K. [2 ]
Iles, Rachel [2 ]
Lip, Gregory Y. H. [1 ]
Davies, Michael K. [4 ]
机构
[1] Sandwell & W Birmingham Hosp NHS Trust, Univ Dept Med, W Bromwich, W Midlands, England
[2] Univ Birmingham, Dept Primary Care & Gen Practice, Birmingham, W Midlands, England
[3] Univ Glamorgan, Mid Glamorgan, Wales
[4] Univ Hosp Birmingham NHS Trust, Dept Cardiol, Birmingham, W Midlands, England
来源
EUROPACE | 2012年 / 14卷 / 11期
关键词
Atrial fibrillation; Prevalence; Mortality; Risk factors; RANDOMIZED CONTROLLED-TRIAL; ANTITHROMBOTIC THERAPY; STROKE PREVENTION; COMMUNITY; WARFARIN; ANTICOAGULANTS;
D O I
10.1093/europace/eus087
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Aims To establish the prevalence of atrial fibrillation (AF) in the general population in the UK, and in those with risk factors. Methods and results The prevalence of AF on electrocardiography was established in prospectively selected groups: 3960 randomly selected from the population, aged 45+; 782 with a previous diagnosis of heart failure; and 1062 with a record of myocardial infarction, hypertension, angina, or diabetes. Patients were also assessed clinically and with echocardiography. Mortality was tracked for 8 years. Atrial fibrillation was found in 78 of the random population sample (2.0%). Prevalence was 1.6% in women and 2.4% in men, rising with age from 0.2% in those aged 45-54 to 8.0% in those aged 75 and older. Half of all cases were in patients aged 75 and older. Only 23 of the 78 (29.5%) of those in AF took warfarin. Of the 782 patients, 175 (22.4%) with a diagnosis of heart failure were in AF, with normal left ventricular function in 95 (54.3%) of these. Atrial fibrillation was found in 14 of the 244 (5.7%) of those with a history of myocardial infarction, 15 of the 388 (3.9%) of those with hypertension, 15 of the 321 (4.7%) of those with angina, and 11 of the 208 (5.3%) of diabetics. Adjusting for age and sex, mortality was 1.57 times higher for those in AF. Conclusion Atrial fibrillation is common in the elderly and those with clinical risk factors. Screening these groups would identify many with AF. Use of anticoagulation was low at the time of the initial assessments in the late 1990s; practice may have changed recently.
引用
收藏
页码:1553 / 1559
页数:7
相关论文
共 23 条
[1]
Clinical study to investigate the predictive parameters for the onset of atrial fibrillation in patients with essential hypertension [J].
Ciaroni, S ;
Cuenoud, L ;
Bloch, A .
AMERICAN HEART JOURNAL, 2000, 139 (05) :814-819
[2]
Dabigatran versus Warfarin in Patients with Atrial Fibrillation. [J].
Connolly, Stuart J. ;
Ezekowitz, Michael D. ;
Yusuf, Salim ;
Eikelboom, John ;
Oldgren, Jonas ;
Parekh, Amit ;
Pogue, Janice ;
Reilly, Paul A. ;
Themeles, Ellison ;
Varrone, Jeanne ;
Wang, Susan ;
Alings, Marco ;
Xavier, Denis ;
Zhu, Jun ;
Diaz, Rafael ;
Lewis, Basil S. ;
Darius, Harald ;
Diener, Hans-Christoph ;
Joyner, Campbell D. ;
Wallentin, Lars .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (12) :1139-1151
[3]
Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: a population based study [J].
Davies, MK ;
Hobbs, FDR ;
Davis, RC ;
Kenkre, JE ;
Roalfe, AK ;
Hare, R ;
Wosornu, D ;
Lancashire, RJ .
LANCET, 2001, 358 (9280) :439-444
[4]
Dores H, 2011, REV PORT CARDIOL, V30, P171
[5]
Detected atrial fibrillation in North Italy: rates, calculated stroke risk and proportion of patients receiving thrombo-prophylaxis [J].
Filippi, A ;
Bettoncelli, G ;
Zaninelli, A .
FAMILY PRACTICE, 2000, 17 (04) :337-339
[6]
PREVALENCE OF ATRIAL-FIBRILLATION IN ELDERLY SUBJECTS (THE CARDIOVASCULAR HEALTH STUDY) [J].
FURBERG, CD ;
PSATY, BM ;
MANOLIO, TA ;
GARDIN, JM ;
SMITH, VE ;
RAUTAHARJU, PM .
AMERICAN JOURNAL OF CARDIOLOGY, 1994, 74 (03) :236-241
[7]
Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: A meta-analysis [J].
Hart, RG ;
Benavente, O ;
McBride, R ;
Pearce, LA .
ANNALS OF INTERNAL MEDICINE, 1999, 131 (07) :492-+
[8]
Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study [J].
Heeringa, J ;
van der Kuip, DAM ;
Hofman, A ;
Kors, JA ;
van Herpen, G ;
Stricker, BHC ;
Stijnen, T ;
Lip, GYH ;
Witteman, JCM .
EUROPEAN HEART JOURNAL, 2006, 27 (08) :949-953
[9]
A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study [J].
Hobbs, FDR ;
Fitzmaurice, DA ;
Mant, J ;
Murray, E ;
Jowett, S ;
Bryan, S ;
Raftery, J ;
Davies, M ;
Lip, G .
HEALTH TECHNOLOGY ASSESSMENT, 2005, 9 (40) :1-+
[10]
EPIDEMIOLOGIC FEATURES OF CHRONIC ATRIAL-FIBRILLATION - THE FRAMINGHAM-STUDY [J].
KANNEL, WB ;
ABBOTT, RD ;
SAVAGE, DD ;
MCNAMARA, PM .
NEW ENGLAND JOURNAL OF MEDICINE, 1982, 306 (17) :1018-1022